Comparison of particle sizing techniques in the case of inhalation dry powders

被引:45
作者
Bosquillon, C [1 ]
Lombry, C [1 ]
Preat, V [1 ]
Vanbever, R [1 ]
机构
[1] Univ Catholique Louvain, Sch Pharm, Dept Pharmaceut Technol, B-1200 Brussels, Belgium
关键词
primary particle size; inhalation dry powder; laser diffraction; electrical zone sensing; microscopy;
D O I
10.1002/jps.1154
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The objectives of this work were (i) to validate electrical zone sensing and laser diffraction for the analysis of primary particle size in the case of inhalation dry powders and (ii) to study the influence of the aggregation state of the powder on the sizing techniques. Free-flowing dry powders were prepared by spray-drying with a combination of albumin, lactose, and dipalmitoylphosphatidylcholine. The replacement of lactose by mannitol, the removal of albumin, and the atomization at high relative humidity all increased powder cohesion. Automated measurements were compared with primary particle sizes collected by light and electron microscopy. The mass mode obtained by electrical zone sensing and the mass median diameter measured by laser diffraction following dispersion with compressed air at a pressure of 3 bar or following suspension in water and ultrasonic dispersion at a power of 60 W for 30 s each provided primary particle sizes close to microscopy measurements. However, these conditions only applied in the case of slightly to moderately aggregated powders. For strongly agglomerated powders, an exact measurement of the size was only collected by laser diffraction in the wet state combined with ultrasonic dispersion. Our study underlies how measurement of primary particle size highly depends on both powder material and proper particle dispersion. (C) 2001 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 90:2032-2041, 2001.
引用
收藏
页码:2032 / 2041
页数:10
相关论文
共 14 条
[1]   Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance [J].
Bosquillon, C ;
Lombry, C ;
Préat, V ;
Vanbever, R .
JOURNAL OF CONTROLLED RELEASE, 2001, 70 (03) :329-339
[2]   INFLUENCE OF COHESIVE PROPERTIES OF MICRONIZED DRUG POWDERS ON PARTICLE-SIZE ANALYSIS [J].
DEVILLIERS, MM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (03) :191-198
[3]   Large porous particles for pulmonary drug delivery [J].
Edwards, DA ;
Hanes, J ;
Caponetti, G ;
Hrkach, J ;
BenJebria, A ;
Eskew, ML ;
Mintzes, J ;
Deaver, D ;
Lotan, N ;
Langer, R .
SCIENCE, 1997, 276 (5320) :1868-1871
[4]   Particle size analysis: A comparative study of various methods [J].
Etzler, FM ;
Sanderson, MS .
PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION, 1995, 12 (05) :217-224
[5]   CALCULATED DEPOSITION OF INHALED PARTICLES IN THE AIRWAY GENERATIONS OF NORMAL SUBJECTS [J].
GERRITY, TR ;
LEE, PS ;
HASS, FJ ;
MARINELLI, A ;
WERNER, P ;
LOURENCO, RV .
JOURNAL OF APPLIED PHYSIOLOGY, 1979, 47 (04) :867-873
[6]  
Hinds W.C., 1999, Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles, V2nd ed., P42
[7]  
Iacocca RG, 1997, INT J POWDER METALL, V33, P35
[8]  
Martin A., 1993, MARTINS PHYS PHARM P, V4th ed., P423
[9]  
Martonen T.a.Y, 1996, INHALATION AEROSOLS, P3
[10]   Formulation and physical characterization of large porous particles for inhalation [J].
Vanbever, R ;
Mintzes, JD ;
Wang, J ;
Nice, J ;
Chen, DH ;
Batycky, R ;
Langer, R ;
Edwards, DA .
PHARMACEUTICAL RESEARCH, 1999, 16 (11) :1735-1742